{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:24:46Z","timestamp":1792877086950,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"vor","delay-in-days":364,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejpn.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T02:40:57Z","timestamp":1604457657000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["E.U. paediatric MOG consortium consensus: Part 2 \u2013 Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4471-8324","authenticated-orcid":false,"given":"Matthias","family":"Baumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-4520","authenticated-orcid":false,"given":"Frederik","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7665-1171","authenticated-orcid":false,"given":"Carsten","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Adamsbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Hacohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rost\u00e1sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.U. paediatric","family":"Mog consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlette L.","family":"Bruijstens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Breu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Flet-Berliac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali\u00e9nor","family":"de Chalus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgi","family":"Laetitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline","family":"Wassmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Wickstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds","family":"Armangue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaran","family":"Deiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinze F.","family":"Neuteboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2020.10.002_bib1","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2020.10.002_bib2","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1212\/NXI.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ejpn.2020.10.002_bib3","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2020.10.002_bib4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bjophthalmol-2018-313142","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy","volume":"103","author":"Liu","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12732","article-title":"Comparison of clinical outcomes of transverse myelitis among adults with myelin oligodendrocyte glycoprotein antibody vs aquaporin-4 antibody disease","volume":"2","author":"Mariano","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejpn.2020.10.002_bib6","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1212\/WNL.0000000000002878","article-title":"Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders","volume":"87","author":"Rostasy","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2020.10.002_bib7","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/ket398","article-title":"Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy","volume":"53","author":"Twilt","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejpn.2020.10.002_bib8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/0883073813500713","article-title":"Canadian Pediatric Demyelinating Disease N. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children","volume":"29","author":"Yiu","year":"2014","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib9","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000560","article-title":"Pediatric CNS-isolated hemophagocytic lymphohistiocytosis","volume":"6","author":"Benson","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ejpn.2020.10.002_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41582-018-0024-9","article-title":"Neuroimmune disorders of the central nervous system in children in the molecular era","volume":"14","author":"Wells","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib11","first-page":"845","article-title":"MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein","volume":"265","author":"Baumann","year":"2018","journal-title":"J.\u00a0Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2020.10.002_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes","volume":"77","author":"Waters","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejpn.2020.10.002_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"Baumann","year":"2015","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejpn.2020.10.002_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msard.2018.07.022","article-title":"Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders","volume":"26","author":"Konuskan","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ejpn.2020.10.002_bib16","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1177\/1352458516631038","article-title":"Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases","volume":"22","author":"Baumann","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2020.10.002_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2015-311743","article-title":"Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease","volume":"87","author":"Lechner","year":"2016","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejpn.2020.10.002_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/dmcn.13649","article-title":"Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"60","author":"Hacohen","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4 autoimmunity in children","volume":"71","author":"McKeon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2020.10.002_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2020.10.002_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","article-title":"Diagnostic algorithm for relapsing acquired demyelinating syndromes in children","volume":"89","author":"Hacohen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2020.10.002_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp-2014-308550","article-title":"Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features","volume":"86","author":"Absoud","year":"2015","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejpn.2020.10.002_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1352458519893093","article-title":"MRI differences between MOG antibody disease and AQP4 NMOSD","author":"Salama","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2020.10.002_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jnnp-2016-314005","article-title":"Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease","volume":"88","author":"Jurynczyk","year":"2017","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejpn.2020.10.002_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1352458515587751","article-title":"Clinical and MRI phenotype of children with MOG antibodies","volume":"22","author":"Fernandez-Carbonell","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2020.10.002_bib26","first-page":"1945","article-title":"MOG antibody-related disorders: common features and uncommon presentations","volume":"264","author":"Cobo-Calvo","year":"2017","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-020-02132-y","article-title":"The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody","volume":"139","author":"Hoftberger","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib28","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/brain\/awaa102","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study","volume":"143","author":"Takai","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2020.10.002_bib29","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000731","article-title":"Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies","volume":"7","author":"Wegener-Panzer","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ejpn.2020.10.002_bib30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/ene.13790","article-title":"Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China","volume":"26","author":"Wang","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib31","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ejpn.2020.10.002_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejpn.2020.10.002_bib33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/dmcn.13090","article-title":"Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies","volume":"58","author":"Hacohen","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/dmcn.14032","article-title":"Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children","volume":"61","author":"Ramanathan","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib35","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/WNL.0000000000001370","article-title":"Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS","volume":"84","author":"Symmonds","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2020.10.002_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejpn.2020.10.002_bib37","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/dmcn.14114","article-title":"Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children","volume":"61","author":"Tantsis","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib38","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/1352458519849511","article-title":"Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: a retrospective multicentric study","volume":"26","author":"Ciron","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2020.10.002_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib40","article-title":"Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies","author":"Sechi","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2020.10.002_bib41","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X19830475","article-title":"MRI-negative myelitis associated with myelin oligodendrocyte glycoprotein antibody spectrum demyelinating disease","volume":"6","author":"Perez","year":"2019","journal-title":"Child Neurol Open"},{"key":"10.1016\/j.ejpn.2020.10.002_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jns.2019.03.014","article-title":"Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: a cohort study in China","volume":"400","author":"Song","year":"2019","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ejpn.2020.10.002_bib43","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients","volume":"102","author":"Zhao","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"20","key":"10.1016\/j.ejpn.2020.10.002_bib44","first-page":"30073","article-title":"High association of MOG-IgG antibodies in children with bilateral optic neuritis","volume":"S1090\u20133798","author":"Wendel","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2020.10.002_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib47","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/dmcn.13757","article-title":"Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome","volume":"60","author":"Eyre","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.21753","article-title":"Cloud-like enhancement is a magnetic resonance imaging abnormality specific to neuromyelitis optica","volume":"66","author":"Ito","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00234-014-1379-2","article-title":"Vasogenic edema characterizes pediatric acute disseminated encephalomyelitis","volume":"56","author":"Zuccoli","year":"2014","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ejpn.2020.10.002_bib50","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejpn.2020.10.002_bib51","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2020.10.002_bib52","first-page":"1445","article-title":"Diffusion-tensor MR imaging of gray and white matter development during normal human brain maturation","volume":"23","author":"Mukherjee","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ejpn.2020.10.002_bib53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jmri.20281","article-title":"Normal white matter development from infancy to adulthood: comparing diffusion tensor and high b value diffusion weighted MR images","volume":"21","author":"Ben Bashat","year":"2005","journal-title":"J.\u00a0Magn. Reson. Imag."},{"key":"10.1016\/j.ejpn.2020.10.002_bib54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejpn.2016.08.014","article-title":"Evolution of MRI abnormalities in paediatric acute disseminated encephalomyelitis","volume":"21","author":"Wong","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrneurol.2015.106","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process","volume":"11","author":"Rovira","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib56","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamaneurol.2015.0248","article-title":"Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder","volume":"72","author":"Kremer","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejpn.2020.10.002_bib57","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"International Society for Magnetic Resonance in M. Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib58","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/brain\/awx041","article-title":"White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders","volume":"140","author":"Longoni","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2020.10.002_bib59","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/1352458519829698","article-title":"Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure","volume":"25","author":"Bartels","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejpn.2020.10.002_bib60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ana.25754","article-title":"Clinical and magnetic resonance imaging outcome predictors in pediatric anti-N-Methyl-D-Aspartate receptor encephalitis","volume":"88","author":"Bartels","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2020.10.002_bib61","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1212\/WNL.0000000000003884","article-title":"Monophasic demyelination reduces brain growth in children","volume":"88","author":"Aubert-Broche","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2020.10.002_bib62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/WCO.0000000000000222","article-title":"Advances in MRI-based computational neuroanatomy: from morphometry to in-vivo histology","volume":"28","author":"Weiskopf","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.ejpn.2020.10.002_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuroimage.2013.06.005","article-title":"Using high-resolution quantitative mapping of R1 as an index of cortical myelination","volume":"93","author":"Lutti","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejpn.2020.10.002_bib64","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/dneu.22552","article-title":"Advances in noninvasive myelin imaging","volume":"78","author":"Heath","year":"2018","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.ejpn.2020.10.002_bib65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2352-4642(18)30026-9","article-title":"MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study","volume":"2","author":"Fadda","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ejpn.2020.10.002_bib66","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3389\/fneur.2018.01156","article-title":"Predictors of evolution into multiple sclerosis after a first acute demyelinating syndrome in children and adolescents","volume":"9","author":"Papetti","year":"2018","journal-title":"Front. Neurol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379820301951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379820301951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:36:49Z","timestamp":1761071809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379820301951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":66,"alternative-id":["S1090379820301951"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2020.10.002","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E.U. paediatric MOG consortium consensus: Part 2 \u2013 Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}